Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $724.46 | 9 | 97.2% |
| Education | $20.97 | 1 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $339.93 | 3 | $0 (2019) |
| Merck Sharp & Dohme LLC | $222.54 | 2 | $0 (2022) |
| ViiV Healthcare Company | $114.44 | 1 | $0 (2019) |
| Axsome Therapeutics, Inc. | $33.82 | 2 | $0 (2023) |
| Seqirus USA Inc | $20.97 | 1 | $0 (2018) |
| Travere Therapeutics, Inc. | $13.73 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $17.30 | 1 | Axsome Therapeutics, Inc. ($17.30) |
| 2022 | $174.63 | 3 | Merck Sharp & Dohme LLC ($144.38) |
| 2019 | $336.40 | 3 | Gilead Sciences, Inc. ($221.96) |
| 2018 | $217.10 | 3 | Gilead Sciences, Inc. ($117.97) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/06/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Neurology | ||||||
| 11/17/2022 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Neurology | ||||||
| 10/27/2022 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $13.73 | General |
| 10/18/2022 | Merck Sharp & Dohme LLC | VAXNEUVANCE (Biological) | Food and Beverage | In-kind items and services | $144.38 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/16/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $110.91 | General |
| 03/19/2019 | ViiV Healthcare Company | JULUCA (Drug) | Food and Beverage | In-kind items and services | $114.44 | General |
| Category: HIV | ||||||
| 01/24/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $111.05 | General |
| 10/07/2018 | Seqirus USA Inc | — | Education | In-kind items and services | $20.97 | General |
| 09/19/2018 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $78.16 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/01/2018 | Gilead Sciences, Inc. | Biktarvy (Drug) | Food and Beverage | In-kind items and services | $117.97 | General |
| Category: HIV | ||||||
About Dr. Roberto Santos, MD
Dr. Roberto Santos, MD is a Pediatric Infectious Diseases healthcare provider based in Albany, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/07/2007. The National Provider Identifier (NPI) number assigned to this provider is 1285847236.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roberto Santos, MD has received a total of $745.43 in payments from pharmaceutical and medical device companies, with $17.30 received in 2023. These payments were reported across 10 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($724.46).
Practice Information
- Specialty Pediatric Infectious Diseases
- Location Albany, NY
- Active Since 05/07/2007
- Last Updated 11/07/2012
- Taxonomy Code 2080P0208X
- Entity Type Individual
- NPI Number 1285847236
Products in Payments
- VAXNEUVANCE (Biological) $144.38
- Biktarvy (Drug) $117.97
- JULUCA (Drug) $114.44
- ZERBAXA (Drug) $78.16
- Sunosi (Drug) $33.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.